Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,832 | 282 | 50.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,580 | 7 | 48.0% |
| Education | $79.77 | 3 | 0.8% |
| Travel and Lodging | $45.24 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $3,842 | 49 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $1,911 | 39 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $1,038 | 41 | $0 (2021) |
| Lundbeck LLC | $489.55 | 38 | $0 (2021) |
| Shire North American Group Inc | $375.66 | 22 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $358.70 | 21 | $0 (2021) |
| ABBVIE INC. | $236.38 | 9 | $0 (2022) |
| Alkermes, Inc. | $212.13 | 8 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $161.60 | 10 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $158.39 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $153.29 | 7 | ABBVIE INC. ($58.92) |
| 2021 | $705.63 | 38 | AbbVie Inc. ($177.46) |
| 2020 | $196.62 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($64.18) |
| 2019 | $5,419 | 81 | Allergan Inc. ($2,954) |
| 2018 | $1,971 | 82 | Allergan Inc. ($670.87) |
| 2017 | $1,091 | 73 | Otsuka America Pharmaceutical, Inc. ($261.36) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/17/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 02/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2022 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: NEUROLOGY | ||||||
| 01/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: CNS | ||||||
| 01/11/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 01/06/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: CNS | ||||||
| 12/21/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: CNS | ||||||
| 12/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Neuroscience | ||||||
| 12/07/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: CNS | ||||||
| 11/02/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Neuroscience | ||||||
| 10/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2021 | Noven Pharmaceuticals, Inc. | SECUADO (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/07/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: CNS | ||||||
| 09/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: PSYCHIATRY | ||||||
| 09/02/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: PSYCHIATRY | ||||||
| 09/01/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/17/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 79 | 305 | $86,899 | $19,383 |
| 2022 | 3 | 136 | 313 | $84,007 | $22,368 |
| 2021 | 3 | 117 | 558 | $73,220 | $42,083 |
| 2020 | 3 | 145 | 683 | $77,480 | $39,813 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 239 | $71,765 | $15,235 | 21.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 23 | 46 | $11,414 | $3,415 | 29.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 14 | 20 | $3,720 | $732.73 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 180 | $52,596 | $13,658 | 26.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 33 | 33 | $15,147 | $3,803 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 68 | $10,312 | $3,325 | 32.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 16 | 32 | $5,952 | $1,581 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 339 | $47,280 | $27,149 | 57.4% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 16 | 181 | $21,720 | $13,134 | 60.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 21 | 38 | $4,220 | $1,801 | 42.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 95 | 384 | $42,250 | $21,685 | 51.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 20 | 234 | $28,080 | $15,501 | 55.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 30 | 65 | $7,150 | $2,627 | 36.7% |
About Anne Dall
Anne Dall is a Psychiatry healthcare provider based in Lebanon, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548266281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anne Dall has received a total of $9,537 in payments from pharmaceutical and medical device companies, with $153.29 received in 2022. These payments were reported across 294 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,832).
As a Medicare-enrolled provider, Dall has provided services to 477 Medicare beneficiaries, totaling 1,859 services with total Medicare billing of $123,646. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Lebanon, PA
- Active Since 06/27/2005
- Last Updated 02/28/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1548266281
Products in Payments
- VRAYLAR (Drug) $3,879
- LATUDA (Drug) $1,911
- REXULTI (Drug) $826.90
- ABILIFY MAINTENA (Drug) $454.98
- Trintellix (Drug) $304.30
- VYVANSE (Drug) $247.66
- TRINTELLIX (Drug) $218.35
- VIIBRYD (Drug) $200.00
- INGREZZA (Drug) $161.60
- MYDAYIS (Drug) $145.12
- BELSOMRA (Drug) $124.97
- Fanapt (Drug) $115.01
- Adzenys XR-ODT (Drug) $104.25
- BRINTELLIX (Drug) $102.62
- SUNOSI (Drug) $90.65
- Vivitrol 380 mg (Drug) $86.99
- ARISTADA (Drug) $82.12
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $78.72
- CAPLYTA (Drug) $77.06
- JORNAY PM (Drug) $54.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lebanon
Dr. Michael Hill, Md, MD
Psychiatry — Payments: $61,853
Dr. Robert Cotes, Md, MD
Psychiatry — Payments: $59,911
Nhien Nguyen, Md, MD
Psychiatry — Payments: $7,810
Dr. Paul Holtzheimer, Md, MD
Psychiatry — Payments: $7,352
Dr. Kathleen Elnaggar, Md, MD
Psychiatry — Payments: $5,489
Dr. Karen Medzoyan, Md, MD
Psychiatry — Payments: $4,266